Lineage Cell Therapeutics Inc (AMEX:LCTX) has a beta value of 1.33 and has seen 0.7 million shares traded in the recent trading session. The company, currently valued at $99.42M, closed the recent trade at $0.44 per share which meant it lost -$0.01 on the day or -3.60% during that session. The LCTX stock price is -254.55% off its 52-week high price of $1.56 and -2.27% below the 52-week low of $0.45. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.04 million shares traded. The 3-month trading volume is 1.80 million shares.
Lineage Cell Therapeutics Inc (AMEX:LCTX) trade information
Sporting -3.60% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the LCTX stock price touched $0.44 or saw a rise of 15.48%. Year-to-date, Lineage Cell Therapeutics Inc shares have moved -13.36%, while the 5-day performance has seen it change -15.47%. Over the past 30 days, the shares of Lineage Cell Therapeutics Inc (AMEX:LCTX) have changed -14.65%. Short interest in the company has seen 22.34 million shares shorted with days to cover at 18.33.
Lineage Cell Therapeutics Inc (LCTX) estimates and forecasts
The company’s shares have lost -52.68% over the past 6 months. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -2.93% over the past 5 years.
LCTX Dividends
Lineage Cell Therapeutics Inc is expected to release its next earnings report on 2025-Mar-09 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Lineage Cell Therapeutics Inc (AMEX:LCTX)’s Major holders
Insiders own 0.55% of the company shares, while shares held by institutions stand at 53.91% with a share float percentage of 54.20%. Investors are also buoyed by the number of investors in a company, with Lineage Cell Therapeutics Inc having a total of 150.0 institutions that hold shares in the company. The top two institutional holders are BROADWOOD CAPITAL INC with over 41.67 million shares worth more than $41.55 million. As of 2024-06-30, BROADWOOD CAPITAL INC held 22.0675% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 9.56 million shares as of 2024-06-30. The firm’s total holdings are worth over $9.53 million and represent 5.0629% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. As of Dec 31, 2024, the former fund manager holds about 1.93% shares in the company for having 4.42 shares of worth $1.92 million while later fund manager owns 3.67 shares of worth $1.6 million as of Feb 28, 2025, which makes it owner of about 1.61% of company’s outstanding stock.
